LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 708

Search options

  1. Article ; Online: Empirical Considerations of an Unsolved Conundrum: Disability Payments and Work.

    Rosenheck, Robert

    Schizophrenia bulletin

    2022  Volume 49, Issue 1, Page(s) 7–8

    MeSH term(s) Humans ; Insurance, Disability
    Language English
    Publishing date 2022-09-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 439173-1
    ISSN 1745-1701 ; 0586-7614
    ISSN (online) 1745-1701
    ISSN 0586-7614
    DOI 10.1093/schbul/sbac136
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Medicalizing Homelessness: Mistaken Identity, Adaptation to Conservative Times, or Revival of Social Medicine.

    Rosenheck, Robert

    Medical care

    2021  Volume 59, Issue Suppl 2, Page(s) S106–S109

    MeSH term(s) Ill-Housed Persons ; Humans ; Medicalization ; Poverty ; Social Determinants of Health ; Social Medicine ; Social Problems ; United States
    Language English
    Publishing date 2021-02-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 411646-x
    ISSN 1537-1948 ; 0025-7079
    ISSN (online) 1537-1948
    ISSN 0025-7079
    DOI 10.1097/MLR.0000000000001366
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013-2020.

    Rhee, Taeho Greg / Rosenheck, Robert A

    American journal of preventive medicine

    2023  Volume 65, Issue 3, Page(s) 528–533

    Abstract: Introduction: Cannabis use for medical purposes is legalized across 39 states and the District of Columbia in the U.S. The objective of this study was to evaluate temporal trends and correlates of cannabis use for medical purposes in the U.S.: Methods! ...

    Abstract Introduction: Cannabis use for medical purposes is legalized across 39 states and the District of Columbia in the U.S. The objective of this study was to evaluate temporal trends and correlates of cannabis use for medical purposes in the U.S.
    Methods: Data from the 2013-2020 National Survey on Drug Use and Health were used. Since 2013, medical cannabis use has been assessed using a dichotomous question asking whether any medical cannabis use was recommended by a doctor among those who used cannabis in the past 12 months. A modified Poisson model was used to estimate the average annual percentage change in medical cannabis use from 2013 to 2020. The analyses were repeated for key sociodemographic and clinical subgroups. Data were analyzed from September to November 2022.
    Results: The prevalence of U.S. residents using cannabis for medical purposes increased significantly from 1.2% in 2013-2014 to 2.5% in 2019-2020, with an average annual percentage change of 12.9% (95% CI=10.4, 15.5), and many of sociodemographic and clinical subgroups showed similar significant increases in cannabis use for medical purposes. In the multivariable-adjusted model, living in a state that legalized medical cannabis remained significantly associated with medical cannabis use (AOR=4.10; 95% CI=3.68, 4.56).
    Conclusions: The study documents a continued nationwide increase in the use of cannabis for diverse medical purposes between 2013 and 2020, two decades after the first state passed legalizing legislation.
    MeSH term(s) Humans ; Cannabis ; Medical Marijuana/therapeutic use ; Substance-Related Disorders ; District of Columbia ; Prevalence
    Chemical Substances Medical Marijuana
    Language English
    Publishing date 2023-03-12
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 632646-8
    ISSN 1873-2607 ; 0749-3797
    ISSN (online) 1873-2607
    ISSN 0749-3797
    DOI 10.1016/j.amepre.2023.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.

    Havlik, John L / Rhee, Taeho G / Rosenheck, Robert A

    PloS one

    2024  Volume 19, Issue 4, Page(s) e0302544

    Abstract: The association of subjective mental health-related quality of life (MHRQOL) and treatment use among people experiencing common substance use disorders (SUDs) is not known. Furthermore, the association of a given substance's legal status with treatment ... ...

    Abstract The association of subjective mental health-related quality of life (MHRQOL) and treatment use among people experiencing common substance use disorders (SUDs) is not known. Furthermore, the association of a given substance's legal status with treatment use has not been studied. This work aims determine the association of MHRQOL with SUD treatment use, and how substance legal status modulates this relationship. Our analysis used nationally-representative data from the NESARC-III database of those experiencing past-year SUDs (n = 5,808) to compare rates of treatment use and its correlates among three groups: those with illicit substance use disorders (ISUDs); those with partially legal substance use disorders, i.e., cannabis use disorder (CUD); and those with fully legal substance use disorders, i.e., alcohol use disorder (AUD). Survey-weighted multiple regression analysis was used to assess the association of MHRQOL with likelihood of treatment use among these three groups, both unadjusted and adjusted for sociodemographic, behavioral, and diagnostic factors. Adults with past-year ISUDs were significantly more likely to use treatment than those with CUD and AUD. Among those with ISUDs, MHRQOL had no significant association with likelihood of treatment use. Those with past-year CUD saw significant negative association of MHRQOL with treatment use in unadjusted analysis, but not after controlling for diagnostic and other behavioral health factors. Those with past-year AUD had significant negative association of MHRQOL with treatment use in both unadjusted and adjusted analysis. If legalization and decriminalization continue, there may be a greater need for effective public education and harm reduction services to address this changing SUD landscape.
    MeSH term(s) Humans ; Quality of Life ; Male ; Adult ; Substance-Related Disorders/therapy ; Substance-Related Disorders/psychology ; Substance-Related Disorders/epidemiology ; Female ; Mental Health/legislation & jurisprudence ; Middle Aged ; Young Adult ; Adolescent ; Patient Acceptance of Health Care ; Alcoholism/therapy ; Alcoholism/psychology ; Alcoholism/epidemiology
    Language English
    Publishing date 2024-04-29
    Publishing country United States
    Document type Journal Article ; Comparative Study
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0302544
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The challenge of cost-effectiveness research on first-episode psychosis.

    Rosenheck, Robert

    The British journal of psychiatry : the journal of mental science

    2019  Volume 215, Issue 1, Page(s) 386–387

    Abstract: Early intervention in psychosis has generated hope. Cost-effectiveness studies, to determine whether benefits exceed costs, thus far conclude only that early intervention 'might be' worth its costs. It is a testament to the importance of the question: ... ...

    Abstract Early intervention in psychosis has generated hope. Cost-effectiveness studies, to determine whether benefits exceed costs, thus far conclude only that early intervention 'might be' worth its costs. It is a testament to the importance of the question: even in the absence of conclusive data, a synthesis should be attempted.Declaration of interestNone.
    MeSH term(s) Cost-Benefit Analysis ; Humans ; Psychotic Disorders ; Schizophrenia
    Language English
    Publishing date 2019-06-14
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 218103-4
    ISSN 1472-1465 ; 0007-1250
    ISSN (online) 1472-1465
    ISSN 0007-1250
    DOI 10.1192/bjp.2019.78
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Toward Dissemination of Secondary Prevention for Psychosis.

    Rosenheck, Robert

    The American journal of psychiatry

    2018  Volume 175, Issue 5, Page(s) 393–394

    MeSH term(s) Adolescent ; Humans ; Psychotic Disorders ; Secondary Prevention ; Young Adult
    Language English
    Publishing date 2018-05-04
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 280045-7
    ISSN 1535-7228 ; 0002-953X
    ISSN (online) 1535-7228
    ISSN 0002-953X
    DOI 10.1176/appi.ajp.2018.18010029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Provision of Mental Health Services in the Veterans Health Administration: A Nationwide Comparison With Other Providers.

    Loho, Hieronimus / Rosenheck, Robert A

    Psychiatric services (Washington, D.C.)

    2022  Volume 74, Issue 5, Page(s) 472–479

    Abstract: Objective: Public interest in developing a national health care system has grown in the United States, but so have concerns that a large system would provide poor care. The Veterans Health Administration (VHA) is the largest national U.S. health care ... ...

    Abstract Objective: Public interest in developing a national health care system has grown in the United States, but so have concerns that a large system would provide poor care. The Veterans Health Administration (VHA) is the largest national U.S. health care system, and several of its performance measures have been compared with those of non-VHA organizations. However, few studies have compared VHA's overall provision of mental health care services, and this study aimed to fill this gap.
    Methods: Using 2018 National Mental Health Services Survey data, the authors examined the differences in provision of 45 treatment modalities, specialized services, and dedicated programs between self-identified VHA facilities (N=459), non-VHA facilities that serve only adults (N=3,671), and non-VHA facilities that serve all ages (N=6,378).
    Results: Self-identified VHA facilities offered more services (including more treatment modalities, specialized services, and dedicated programs) (mean±SD=24.2±8.9 services) than both non-VHA adult-only facilities (15.4±6.8; Cohen's d=1.11, p<0.001) and non-VHA all-ages facilities (17.1±6.6; Cohen's d=0.90, p<0.001). Notably, VHA facilities were more likely to offer electroconvulsive therapy and telemedicine. VHA facilities were more likely to offer integrated primary care, chronic illness management, supportive housing, vocational rehabilitation, and psychiatric emergency services, among others. Last, VHA facilities were more likely to offer dedicated treatment programs for patients identifying as lesbian, gay, bisexual, or transgender, as well as for patients with posttraumatic stress disorder, traumatic brain injury, or dementia.
    Conclusions: VHA facilities offer no fewer and possibly more comprehensive mental health services per facility than do non-VHA facilities, possibly because VHA represents an integrated and centralized health system.
    MeSH term(s) Adult ; Female ; Humans ; United States ; Veterans Health ; Veterans/psychology ; United States Department of Veterans Affairs ; Stress Disorders, Post-Traumatic ; Mental Health Services
    Language English
    Publishing date 2022-10-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1220173-x
    ISSN 1557-9700 ; 1075-2730
    ISSN (online) 1557-9700
    ISSN 1075-2730
    DOI 10.1176/appi.ps.202100713
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Admissions to substance use treatment facilities for cannabis use disorder, 2000-2017: Does legalization matter?

    Rhee, Taeho Greg / Rosenheck, Robert A

    The American journal on addictions

    2022  Volume 31, Issue 5, Page(s) 423–432

    Abstract: Background and objectives: A growing number of US states have legalized marijuana use in the past decade. We examined if marijuana legalization is associated with increased marijuana-related admissions to substance use treatment facilities between 2000 ... ...

    Abstract Background and objectives: A growing number of US states have legalized marijuana use in the past decade. We examined if marijuana legalization is associated with increased marijuana-related admissions to substance use treatment facilities between 2000 and 2017.
    Methods: Data from the Treatment Episode Data Set-Admissions were used to examine the relationship between marijuana-related admissions among adults aged ≥18 by year and legalization status (i.e., fully legalized, medical use only [partially legalized], and illegal) (N = 35,457,854). Using interaction analyses, we further examined whether certain patient characteristics were associated with residence in states that legalized marijuana use as compared to those in which marijuana remained illegal.
    Results: Overall, the proportion of marijuana-related admissions in states with legalization decreased by 2.3% from 31.7% in 2000-2005 to 29.4% in 2012-2017 (odds ratio [OR], 0.90; 95% confidence intervals [CI], 0.89-0.90) with little difference from states where marijuana use remained illegal, in which marijuana use as any reason for admissions decreased by 0.3% from 39.8% in 2000-2005 to 39.5% in 2012-2017 (OR, 0.99; 95% CI, 0.98-0.99). We did not find any striking patient characteristics (e.g., referral by the police) associated with admissions in states that legalized compared to those that had not.
    Discussion and conclusions: While earlier studies suggested that marijuana legalization is associated with increased levels of use, emergency department visits, and traffic fatalities, our findings suggest that marijuana legalization did not increase marijuana-related treatment use in the United States.
    Scientific significance: This is the first study to examine the association of marijuana legalization with marijuana-related treatment use.
    MeSH term(s) Adult ; Cannabis ; Hallucinogens ; Humans ; Legislation, Drug ; Marijuana Abuse/epidemiology ; Marijuana Abuse/therapy ; Marijuana Smoking ; Medical Marijuana ; Substance-Related Disorders ; United States/epidemiology
    Chemical Substances Hallucinogens ; Medical Marijuana
    Language English
    Publishing date 2022-04-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1141440-6
    ISSN 1521-0391 ; 1055-0496
    ISSN (online) 1521-0391
    ISSN 1055-0496
    DOI 10.1111/ajad.13286
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Early intervention in psychosis: p-values, policy, and politics.

    Rosenheck, Robert

    World psychiatry : official journal of the World Psychiatric Association (WPA)

    2017  Volume 16, Issue 3, Page(s) 270–271

    Language English
    Publishing date 2017-09-21
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2236130-3
    ISSN 2051-5545 ; 1723-8617
    ISSN (online) 2051-5545
    ISSN 1723-8617
    DOI 10.1002/wps.20450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Receipt of Electroconvulsive Therapy in Outpatient Settings in a National Sample of Privately Insured Patients With Mood Disorders.

    Agbese, Edeanya / Leslie, Douglas L / Rosenheck, Robert

    The journal of ECT

    2023  Volume 40, Issue 1, Page(s) 31–36

    Abstract: Purpose: Electroconvulsive therapy (ECT), an effective treatment for bipolar and major depressive disorder, is underused. Little information is available on use of ECT in potentially less costly outpatient settings, possibly reducing cost barriers.: ... ...

    Abstract Purpose: Electroconvulsive therapy (ECT), an effective treatment for bipolar and major depressive disorder, is underused. Little information is available on use of ECT in potentially less costly outpatient settings, possibly reducing cost barriers.
    Methods: Insurance claims from the 2008 to 2017 MarketScan Commercial Database for patients diagnosed with mood disorders were used to compare 4 groups of ECT users in each year: those receiving (1) exclusively outpatient ECT, (2) first inpatient and subsequently outpatient, (3) outpatient and subsequently inpatient, and (4) exclusively inpatient ECT. Groups were compared on the proportion receiving ECT in each group over time as well as on the total numbers of treatments received along with group differences in sociodemographic and diagnostic characteristics and health care costs.
    Results: Among 2.9 million patients diagnosed with mood disorders, the proportion who received ECT (n = 8859) was small (0.30%) and declined over the decade to 0.17%. Among those who received ECT, most did so exclusively as outpatients (52.3%), the group with fewest comorbidities and lowest costs. This proportion increased by 19.7% over the decade, whereas the proportion receiving ECT exclusively in an inpatient setting (12.1%) fell by 30.6%. The total number of treatments per patient averaged 11.7 per year and increased by 28.0% over the decade, with outpatients decreasing to slightly less than average. Health care costs were greatest for those who started ECT as inpatients.
    Conclusions: Although the proportion of privately insured patients receiving ECT in outpatient settings has increased, reducing cost barriers, the use of ECT continued to be extremely limited and declining.
    MeSH term(s) Humans ; Mood Disorders/therapy ; Electroconvulsive Therapy ; Depressive Disorder, Major/therapy ; Outpatients ; Hospitalization ; Insurance, Health
    Language English
    Publishing date 2023-07-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1426385-3
    ISSN 1533-4112 ; 1095-0680
    ISSN (online) 1533-4112
    ISSN 1095-0680
    DOI 10.1097/YCT.0000000000000950
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top